Enhance your nephrology practice with CME and tools focused on kidney medicine.
Advancing Patient-Centered, Guideline-Driven Management of Hyperkalemia in Adults With CKD and Associated Comorbidities
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
Pauline A. Swift, PhD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
Ellie Kelepouris, MD, FACP, FAHA
The Patient-Clinician Connection in Managing CKD-aP
Lucio Manenti, MD, PhD
CKD-aP or Something Else? Decoding the Diagnosis
Emilio Sanchez, MD, PhD
Is CKD-aP Hiding in Your Dialysis Center?
Elevating CKD-aP Care: New Frontier
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Improving Sleep and Mental Health in Patients with CKD-aP
Leonie Kraft, MD
Kappa-Opioid Settings: Real-World Evidence Insights
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Potassium Binders in Practice: Clinical Trial Evidence
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Claudia Seikrit, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CKD-aP Treatment Tool Kit
Future Directions in Managing Hyperkalemia in CKD and HF
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Sydney Tang, MBBS, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.